Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Elisabeth H. Thijssen(University of California, San Francisco), Renaud La Joie(University of California, San Francisco), Amy Wolf(University of California, San Francisco), Amelia Strom(University of California, San Francisco), Ping Wang(University of California, San Francisco), Leonardo Iaccarino(University of California, San Francisco), Viktoriya Bourakova(University of California, San Francisco), Yann Cobigo(University of California, San Francisco), Hilary W. Heuer(University of California, San Francisco), Salvatore Spina(University of California, San Francisco), Lawren VandeVrede(University of California, San Francisco), Xiyun Chai(Eli Lilly (United States)), Nicholas K. Proctor(Eli Lilly (United States)), David Airey(Eli Lilly (United States)), Sergey Shcherbinin(Eli Lilly (United States)), Cynthia Evans(Eli Lilly (United States)), John R. Sims(Eli Lilly (United States)), Henrik Zetterberg(Sahlgrenska University Hospital), Kaj Blennow(Sahlgrenska University Hospital), Anna M. Karydas(University of California, San Francisco), Charlotte E. Teunissen(Amsterdam Neuroscience), Joel H. Kramer(University of California, San Francisco), Lea T. Grinberg(University of California, San Francisco), William W. Seeley(University of California, San Francisco), Howie Rosen(University of California, San Francisco), Bradley F. Boeve(Mayo Clinic in Arizona), Bruce L. Miller(University of California, San Francisco), Gil D. Rabinovici(University of California, San Francisco), Jeffrey L. Dage(Eli Lilly (United States)), Julio C. Rojas(University of California, San Francisco), Adam L. Boxer(University of California, San Francisco)
Nature Medicine
March 1, 2020
Cited by 796Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis